. 2017 Jul 24;2017:9747256. doi: 10.1155/2017/9747256

Table 4.

Effects of L-theanine administration on the transcript levels of glucose transporters and receptors in rat intestine.

Item	Treatments (mg/kg BW·d)				P value
Item	0	50	200	400	Linear	Quadratic
Jejunum
SGLT1	1.00^ab	1.14 ± 0.20^ab	0.80 ± 0.21^b	1.65 ± 0.21^a	NS	NS
SGLT3	1.00^ab	1.06 ± 0.15^a	0.53 ± 0.16^b	0.03 ± 0.15^c	<0.001	NS
GLUT2	1.00^ab	1.44 ± 0.2^a	0.77 ± 0.20^b	1.12 ± 0.17^ab	NS	NS
GLUT5	1.00^a	0.16 ± 0.08^c	0.72 ± 0.10^b	0.68 ± 0.10^b	NS	NS
Ileum
SGLT1	1.00^a	0.60 ± 0.12^b	0.17 ± 0.11^c	1.10 ± 0.09^a	NS	<0.001
SGLT3	1.00^a	0.61 ± 0.07^b	0.26 ± 0.06^c	0.01 ± 0.005^d	<0.001	<0.001
GLUT2	1.00^c	3.07 ± 0.30^a	1.31 ± 0.33^bc	1.99 ± 0.30^b	NS	NS
GLUT5	1.00^a	0.58 ± 0.10^b	0.53 ± 0.11^b	0.46 ± 0.11^b	0.003	NS

BW: body weight, SGLT1: sodium dependent glucose transporter 1, SGLT3: sodium dependent glucose transporter 3, GLUT2: glucose transporter protein, member 2, GLUT5: glucose transporter protein, member 5, and NS: not significant. ^a–dMeans within a row not bearing a common superscript letter differ (P < 0.05). Data were reported as mean ± SE.